Cleared Traditional

K883011 - MRI NEO-TRYP TRYPSIN RIA

K883011 is an FDA 510(k) clearance for MRI NEO-TRYP TRYPSIN RIA, manufactured by Microbiological Research Corp.. The device is a Class 1 Chemistry device with product code JNO cleared through the Traditional 510(k) pathway after a 281-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1989
Decision
281d
Days
Class 1
Risk

K883011 is an FDA 510(k) clearance for the MRI NEO-TRYP TRYPSIN RIA. Classified as N-benzoyl-l-arginine Ethyl Ester (u.v.), Trypsin (product code JNO), Class I - General Controls.

Submitted by Microbiological Research Corp. (Laguna Hills, US). The FDA issued a Cleared decision on April 26, 1989 after a review of 281 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1725 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K883011

510(k) Number K883011 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 1988
Decision Date April 26, 1989
Days to Decision 281 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
192d slower than avg
Panel avg: 89d · This submission: 281d
Pathway characteristics
Predicate-based equivalence.

JNO Device Classification - Class 1, General Controls

Product Code JNO N-benzoyl-l-arginine Ethyl Ester (u.v.), Trypsin
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1725
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JNO N-benzoyl-l-arginine Ethyl Ester (u.v.), Trypsin

Devices cleared under the same product code (JNO) and FDA review panel - the closest regulatory comparables to K883011.
AUTODELFIA NEONATAL IRT KIT
K110274 · Wallac Oy, A Subsidiary of Perkinelmer, Inc. · Jun 2011
GSP NEONATAL IRT KIT (3306-001U)
K102419 · Wallac Oy, Subsidiary of Perkinelmer · Dec 2010
NUCLITRYP(TM)(I125)-HUMAN PANCREA CATH TRY RAD KIT
K932406 · Nuclear Diagnostics, Inc. · Dec 1993
TRYPSIN RIA KIT
K861097 · Microanalytic Research, Inc. · May 1986
TRYPIN (125I) RIA KIT
K811805 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1981
RIA KIT FOR TRYPSIN
K791202 · Cis Radiopharmaceuticals, Inc. · Nov 1979